Medicine Quality Alert: Class II Medicine Recall of Doximar (Doxycycline 100mg) Capsules Batch Number BPL 281A
The Pharmacy and Poisons Board has mandated Biopharma Ltd to recall Doximar (Doxycycline 100mg) Capsules
From: Pharmacy and Poisons Board
Published: 1st August 2024
Recall Reference Number: REC/2024/018
Recall Classification: Class II
Recall Level: Retail/Facility level
Manufacturer: Biopharma Ltd, Kenya
Product name: Doximar Capsules
Active Pharmaceutical Ingredient: Doxycycline 100mg
Affected Counties: All
Affected Batches
Batch Number | Date of Manufacture | Date of expiry | Pack Size |
BPL 149A | 08/23 | 07/26 | 100’s |
Brief description of the problem
The Pharmacy and Poisons Board (PPB) collected samples of Doximar (Doxycycline 100) Batch No. BPL281A, manufactured by Biopharma Ltd, during routine market surveillance activities, for purposes of quality control testing to check compliance with the registered specifications. The test results found that the product fails to comply with specifications on the test parameters for assay, dissolution, and weight variation.
Action for healthcare professionals
Quarantine all remaining stock and stop further distribution, sale, issuing or use of the above batches immediately. Await contact from Biopharma Ltd to arrange return.
Action for patients and caregivers
No further action is required by patients as this is a Retail/hospital Pharmacy and Wholesaler/Distributor level recall. You are advised to talk to your healthcare professional if you have the above batch of Doximar capsules.
Further Information
For inquiries on consignments of the impacted batches please contact Biopharma Ltd at: info@biopharmaltd.com Tel: +254 717768794
Promptly report any case(s) of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:
- https://pv.pharmacyboardkenya.org/users/mpublic
- USSD code at *271#
- Email pv@ppb.go.ke or pms@ppb.go.ke
- Telephone No. 0795743049
- Mobile application: mPvERS both Android and iOS
For any further enquiries and feedback on the product recall, kindly contact the post-marketing surveillance unit of The Pharmacy and Poisons Board Kenya via email at pms@ppb.go.ke
Download document
Medicine Quality Alert: Class II Medicine Recall of Doximar (Doxycycline 100mg) Capsules Batch number BPL 281A